Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Other Non-Current Liabilities (2018 - 2026)

Profound Medical has reported Other Non-Current Liabilities over the past 6 years, most recently at $79000.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities rose 11.27% year-over-year to $79000.0; the TTM value through Dec 2025 reached $79000.0, up 11.27%, while the annual FY2025 figure was $79000.0, 11.27% up from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $79000.0 at Profound Medical, up from $76000.0 in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $79000.0 in Q4 2025 and troughed at $71000.0 in Q4 2024.
  • A 3-year average of $74000.0 and a median of $73000.0 in 2023 define the central range for Other Non-Current Liabilities.
  • Biggest five-year swings in Other Non-Current Liabilities: fell 2.74% in 2024 and later grew 11.27% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $73000.0 in 2023, then fell by 2.74% to $71000.0 in 2024, then grew by 11.27% to $79000.0 in 2025.
  • Business Quant data shows Other Non-Current Liabilities for PROF at $79000.0 in Q4 2025, $76000.0 in Q3 2025, and $77000.0 in Q2 2025.